These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1430 related articles for article (PubMed ID: 12775192)

  • 41. The mechanisms of action of St. John's wort: an update.
    Schmidt M; Butterweck V
    Wien Med Wochenschr; 2015 Jun; 165(11-12):229-35. PubMed ID: 26183728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neural monoaminergic mediation of the effect of St. John's wort extract on prepulse inhibition of the acoustic startle response in rats.
    Khalifa AE
    J Psychopharmacol; 2005 Sep; 19(5):467-72. PubMed ID: 16166183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
    Capasso R; Borrelli F; Capasso F; Mascolo N; Izzo AA
    Urology; 2004 Jul; 64(1):168-72. PubMed ID: 15245964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Usefulness of studies on the molecular mechanism of action of herbals/botanicals: The case of St. John's wort.
    Choudhuri S; Valerio LG
    J Biochem Mol Toxicol; 2005; 19(1):1-11. PubMed ID: 15736155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.
    Whiskey E; Werneke U; Taylor D
    Int Clin Psychopharmacol; 2001 Sep; 16(5):239-52. PubMed ID: 11552767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperforin as a possible antidepressant component of hypericum extracts.
    Chatterjee SS; Bhattacharya SK; Wonnemann M; Singer A; Müller WE
    Life Sci; 1998; 63(6):499-510. PubMed ID: 9718074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV; Bhattacharya SK; Ghosal S
    Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men.
    Siepmann M; Krause S; Joraschky P; Mück-Weymann M; Kirch W
    Br J Clin Pharmacol; 2002 Sep; 54(3):277-82. PubMed ID: 12236848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
    Hostanska K; Reichling J; Bommer S; Weber M; Saller R
    Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
    Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].
    Röder C; Schaefer M; Leucht S
    Fortschr Neurol Psychiatr; 2004 Jun; 72(6):330-43. PubMed ID: 15211398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do other Hypericum species have medical potential as St. John's wort (Hypericum perforatum)?
    Stojanović G; Ðorđević A; Šmelcerović A
    Curr Med Chem; 2013; 20(18):2273-95. PubMed ID: 23521674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of St. John's wort for the treatment of major depression.
    Nangia M; Syed W; Doraiswamy PM
    Public Health Nutr; 2000 Dec; 3(4A):487-94. PubMed ID: 11276296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. St. John's Wort: is it effective and harmless?
    Biron CR
    RDH; 1999 Jun; 19(6):74-6. PubMed ID: 10895712
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of serotonergic antidepressants and St John's wort in older Australians: a population-based cohort study.
    Rahman SZ; Basilakis J; Rahmadi A; Lujic S; Musgrave I; Jorm L; Hay P; Münch G
    Australas Psychiatry; 2013 Jun; 21(3):262-6. PubMed ID: 23439542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of St John's wort in major depression: a randomized controlled trial.
    Shelton RC; Keller MB; Gelenberg A; Dunner DL; Hirschfeld R; Thase ME; Russell J; Lydiard RB; Crits-Cristoph P; Gallop R; Todd L; Hellerstein D; Goodnick P; Keitner G; Stahl SM; Halbreich U
    JAMA; 2001 Apr; 285(15):1978-86. PubMed ID: 11308434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1.
    Schwarz D; Kisselev P; Roots I
    Cancer Res; 2003 Nov; 63(22):8062-8. PubMed ID: 14633740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.
    Jakobs D; Hage-Hülsmann A; Prenner L; Kolb C; Weiser D; Häberlein H
    J Pharm Pharmacol; 2013 Jun; 65(6):907-15. PubMed ID: 23647684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver.
    Dostalek M; Pistovcakova J; Jurica J; Sulcova A; Tomandl J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):253-7. PubMed ID: 22286810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
    Obach RS
    J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.